Search Results - "Fey, Sigrid K."
-
1
Targeting the Metabolic Response to Statin-Mediated Oxidative Stress Produces a Synergistic Antitumor Response
Published in Cancer research (Chicago, Ill.) (15-01-2020)“…Statins are widely prescribed inhibitors of the mevalonate pathway, acting to lower systemic cholesterol levels. The mevalonate pathway is critical for…”
Get full text
Journal Article -
2
Dark force rising: Reawakening and targeting of fetal-like stem cells in colorectal cancer
Published in Cell reports (Cambridge) (25-06-2024)“…Stem cells play pivotal roles in maintaining intestinal homeostasis, orchestrating regeneration, and in key steps of colorectal cancer (CRC) initiation and…”
Get full text
Journal Article -
3
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo
Published in Nature communications (02-01-2024)“…Oncogenic KRAS mutations are well-described functionally and are known to drive tumorigenesis. Recent reports describe a significant prevalence of KRAS allelic…”
Get full text
Journal Article -
4
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Cancer-associated fibroblasts (CAF) are major contributors to pancreatic ductal adenocarcinoma (PDAC) progression through protumor signaling and the generation…”
Get full text
Journal Article -
5
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition
Published in Cancer research (Chicago, Ill.) (16-10-2024)“…Pancreatic cancer is characterized by the prevalence of oncogenic mutations in KRAS. Previous studies have reported that altered KRAS gene dosage drives…”
Get full text
Journal Article -
6
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer
Published in Nature genetics (01-01-2021)“…Oncogenic KRAS mutations and inactivation of the APC tumor suppressor co-occur in colorectal cancer (CRC). Despite efforts to target mutant KRAS directly, most…”
Get full text
Journal Article -
7
Abstract A004: KRAS allelic imbalance drives an epithelial MAPK-dependent tumor initiation program that is inefficient in provoking metastasis in colorectal cancer in vivo
Published in Molecular cancer research (01-05-2023)“…Abstract Allelic imbalance is reported to be a frequent event in cancers and a common feature associated with oncogenes such as KRAS and BRAF. However the…”
Get full text
Journal Article